{"id":52295,"date":"2021-04-05T12:49:00","date_gmt":"2021-04-05T12:49:00","guid":{"rendered":"https:\/\/www.verificat.cat\/sinopharm-beijing-and-sinopharm-wuhan-work\/"},"modified":"2021-04-05T12:49:00","modified_gmt":"2021-04-05T12:49:00","slug":"sinopharm-beijing-and-sinopharm-wuhan-work","status":"publish","type":"post","link":"https:\/\/www.verificat.cat\/en\/sinopharm-beijing-and-sinopharm-wuhan-work\/","title":{"rendered":"Sinopharm-Beijing and Sinopharm-Wuhan"},"content":{"rendered":"<p><br \/>\n<\/p>\n<p>The National Chinese Pharmaceutical Group, known as <a href=\"http:\/\/www.sinopharm.com\/en\/1398.html\" target=\"_blank\" rel=\"noopener\">Sinopharm<\/a>, has developed two vaccines: <a href=\"http:\/\/www.sinopharm.com\/en\/s\/1395-4173-38923.html\" target=\"_blank\" rel=\"noopener\">Sinopharm-Beijing<\/a> and Sinopharm-Wuhan.<\/p>\n<p>The Institute of Biological Products from Beijing has participated in the development of the first vaccine. It is about a <a href=\"http:\/\/www.sinopharm.com\/en\/s\/1395-4173-38923.html\" target=\"_blank\" rel=\"noopener\">virus-inactivated vaccine<\/a> i.e. it uses a <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7189890\/\" target=\"_blank\" rel=\"noopener\">non-infectious variant of the virus<\/a> causing the disease. Despite the fact that the variant can not produce the infection, it triggers an immune response.&nbsp;<\/p>\n<p>In November 2020, the Chinese corporation assured that <a href=\"http:\/\/www.sinopharm.com\/en\/s\/1395-4689-38997.html\" target=\"_blank\" rel=\"noopener\">phase III<\/a> of the clinical trial was being conducted in the United Arab Emirates, Bahrein, Egypt, Jordan, Morocco, Peru, and Argentina with more than 50,000 volunteers. The results guaranteed <a href=\"https:\/\/www.reuters.com\/article\/health-coronavirus-vaccine-china-idUSKBN297035\" target=\"_blank\" rel=\"noopener\">efficacy of 79,3%<\/a> after <a href=\"https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(20)30831-8\/fulltext\" target=\"_blank\" rel=\"noopener\">two doses<\/a> administered with <a href=\"https:\/\/www.nature.com\/articles\/s41541-021-00292-w\" target=\"_blank\" rel=\"noopener\">21 days difference<\/a>. Presently, <a href=\"https:\/\/covid19.trackvaccines.org\/vaccines\/5\/\" target=\"_blank\" rel=\"noopener\">27 countries<\/a> from Asia, Africa, and Latin America are administering this vaccine.&nbsp;<\/p>\n<p>The <a href=\"http:\/\/www.sinopharm.com\/en\/s\/1395-4173-38923.html\" target=\"_blank\" rel=\"noopener\">most frequent adverse reactions<\/a> are pain at the inoculation site, headache, fever, and muscle pain. None of the side effects reported after 28 days post-vaccination were <a href=\"https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(20)30831-8\/fulltext\" target=\"_blank\" rel=\"noopener\">serious<\/a> during phases I and II.<\/p>\n<p>There is not much available information about the second vaccine, named Sinopharm-Wuhan, in which the Institute of Biological Products of Wuhan has collaborated.<\/p>\n<p>Just as his sister Sinopharm-Beijing, this is a <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04510207#contacts\" target=\"_blank\" rel=\"noopener\">virus-inactivated vaccine<\/a> that seeks to trigger an immune response of the organism through the inoculation of a non-infectious variant of the virus.&nbsp;<\/p>\n<p>Phase III of the clinical trial was conducted in <a href=\"http:\/\/www.chictr.org.cn\/showprojen.aspx?proj=62581\" target=\"_blank\" rel=\"noopener\">Morocco,<\/a> <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04612972\" target=\"_blank\" rel=\"noopener\">Peru,<\/a> <a href=\"http:\/\/www.chictr.org.cn\/showprojen.aspx?proj=56651\" target=\"_blank\" rel=\"noopener\">United Arab Emirates<\/a>, and <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04510207#contacts\" target=\"_blank\" rel=\"noopener\">other countries from the Middle East<\/a> mobilising 66,600 volunteers. For this vaccine, a 2-doses strategy was tested, reaching a <a href=\"https:\/\/www.reuters.com\/article\/us-health-coronavirus-vaccine-sinopharm-idUSKBN2AO0WW\" target=\"_blank\" rel=\"noopener\">72,5% efficacy<\/a>.&nbsp;<\/p>\n<p>The results, nonetheless, have not been published officially and the administration period is unknown, as well as the side effects. Up to now, this vaccine is only available in <a href=\"https:\/\/covid19.trackvaccines.org\/vaccines\/16\/\" target=\"_blank\" rel=\"noopener\">China and the United Arab Emirates<\/a>.<\/p>\n<p>Sinopharm has not either specified the preservation temperature of both vaccines.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The National Chinese Pharmaceutical Group, known as Sinopharm, has developed  [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[169],"tags":[208],"class_list":["post-52295","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-vaccines-en","vc-legacy-post"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/posts\/52295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/comments?post=52295"}],"version-history":[{"count":0,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/posts\/52295\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/media?parent=52295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/categories?post=52295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/tags?post=52295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}